Bookmark and Share

Last Minute: "Democrats celebrating New Zealand gun ban expose the Left's authoritarian impulses - Washington Examiner" Thu, 21 Mar 2019 18:01:00 GMT    "Jimmy Carter becomes oldest living American president - NBC News" Fri, 22 Mar 2019 02:52:00 GMT   "Trump recognizes the high-ground reality in the Golan Heights - Washington Examiner" Thu, 21 Mar 2019 18:04:00 GMT    "EU leaders agree to short-term Brexit delay, granting PM Theresa May a lifeline - Fox News" Fri, 22 Mar 2019 01:02:31 GMT    "ACLU: Black Man Detained While Moving into Own Home -" Thu, 21 Mar 2019 23:09:10 GMT    "College costs, student debt, job prospects: All 3 will be improved with Trump's executive order - Washington Examiner" Thu, 21 Mar 2019 19:14:00 GMT    "Historic river flooding in Central US to continue for weeks - AOL" Thu, 21 Mar 2019 21:21:30 GMT    "China chemical blast death toll rises to 47 - BBC News" Fri, 22 Mar 2019 01:45:19 GMT    "Indiana Teachers Say They Were Shot ?Execution Style? With Pellet Guns in Active Shooter Training - Slate" Thu, 21 Mar 2019 18:44:00 GMT    "US Sanctions Chinese Firms Over Alleged North Korea Trade - TIME" Fri, 22 Mar 2019 01:50:59 GMT      For more news, click here.

Remember me? 

Rise of
+0.15 (+1.00%) Merck & Company - [Ticker: MRK]Chart Merck & Company  News Merck & Company  Download Historical Prices for Metastock Merck & Company and Others  Technical Analysis Merck & Company  
Last Trade79.37Last Trade Time2018-12-04 - 00:00:00
Variation+0.15 (+1.00%)Open79.30
Volume4,330,639Average Volume (3m)0
YieldBid / Ask55.43 x 900 - 55.44 x 2,100
Former Close79.2252 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Merck & Company -  [Ticker: MRK] chart
Change to Merck & Company Interactive Technical Analysis Chart

Last 10 Forum Topics about Merck & Company:
No topics about Merck & Company [MRK] have been found, but a search on the Forum for more topics related to Merck & Company is advised.

 News about Merck & Company [MRK]:   (ordered by relevance)
  1. Merck to Acquire Immune Design  Business Wire
  2. Merck to Buy Immunotherapy Developer Immune Design for $300M
  3. Seattle biotech?s shares quadruple on news of Merck buyout  Seattle Times
  4. Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline  Genetic Engineering & Biotechnology News
  5. Merck takes a shot on Immune Design  BioPharma Dive
  6. View full coverage on Google News
Merck Foundation meets the President and the First Lady of Burundi to launch their programs in the country  africanews

Merck Foundation ( launched their programs in partnership with Burundi's First Lady together with Ministry of Health and ...

Merck, NGM Bio extend research deal through 2022  BioPharma Dive

Merck & Co has exercised its option to extend for an additional two years a five-year deal inked with NGM Biopharmaceuticals back in 2015, taking the ...

Dalcor Holds Firm on Plans for Dalcetrapib Despite Negative Merck Results  GenomeWeb

NEW YORK (GenomeWeb) ?Pharma firm Dalcor remains optimistic regarding its work to salvage the cardiology drug dalcetrapib and see it approved by the US ...

Merck KGaA to invest 1 billion euros in German HQ  BioPharma Dive

Merck KGaA will invest 1 billion euros, or about $1.14 billion in its global headquarters in Darmstadt, Germany over the next five years, the company said ...

Merck doubles down on NGM Bio pact but culls obesity drug  FierceBiotech

Back in 2015, Merck penned a $450 million R&D pact with little NGM Bio for a broad range of early-stage assets. Today, Merck is extending this pact, although ...

Poultry Science Association Foundation announces Merck Animal Health half million endowment pledge for PhD student support

USA -Merck Animal Health was acknowledged as the Inaugural Founder Donor in the Poultry Science Association Foundation (PSA Foundation) during the at ...

Merck's refreshed HPV vaccine push puts Mom in the spotlight  FiercePharma

Merck continues its HPV awareness campaign with a twist. In a new TV ad, a parent serves as narrator for the first time in the three-year-old campaign, ...

Merck-backed health education company weighs sale  Private Equity News

StayWell, a Vestar Capital Partners-backed employee health education company majority owned by a unit of Merck & Co., is weighing a possible sale.

Merck plans to invest ?1 billion at the Darmstadt site  ChemEngOnline

Merck KGaA (Darmstadt, Germany; says that the company management and the Joint Works Council have signed a comprehensive ...

Merck and Pfizer stop third Bavencio ovarian cancer trial  pharmaphorum

Merck and Pfizer are discontinuing the Phase III JAVELIN Ovarian PARP 100 study evaluating Bavencio (avelumab) in advanced ovarian cancer.

Merck KGaA investing ?1B at headquarters site as part of 5-year work agreement  FiercePharma

Merck KGaA's headquarters site in Darmstadt, Germany, is the pride of its international operations, and it intends to keep it that way. The German drug and ...

Merck (MRK) Gains As Market Dips: What You Should Know

In the latest trading session, Merck (MRK) closed at $81.91, marking a +0.69% move from the previous day.

Post-GSK purchase, Tesaro readies for cancer clash with Merck  Boston Business Journal

A new GlaxoSmithKline subsidiary is developing another cancer-fighting drug that it believes could go toe-to-toe with the current market leader, Merck's ...

A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says  Barron's

Merck stock (MRK) is rising on Wednesday, following a note from Cantor Fitzgerald highlighting a big sales runway for its blockbuster cancer treatment in China.

Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study

Pfizer (PFE) and Merck KGaA terminate a late-stage study on Bavencio and its new PARP inhibitor, Talzenna. This is the third ovarian cancer study failure in less ...

Merck KGaA Opens Development Center in France and Invests in Darmstadt Headquarters  Pharmaceutical Technology Magazine

Merck KGaA opened a collaborative bio/pharma development facility in Molsheim, France and announced an investment plan through 2025 for its Darmstadt, ...

Merck launches next live poultry vaccine in U.S.  Feedstuffs

Merck Animal Health, a division of Merck & Co, announced the launch of Innovax ND-ILT, made with biotechnology that protects against three highly infectious ...

Biotech Analysis Central Pharma News: AbbVie's Trouble, Merck KGaA's Bad Streak, Puma's Positive Data  Seeking Alpha

AbbVie and Roche have trouble with Venclexta as partial clinical hold is placed. Merck KGaA And Pfizer suffer a bad luck streak after latest Bavencio trial Fail.

Investors Sell Shares of Merck & Co., Inc. (MRK) on Strength (MRK)  Fairfield Current

Traders sold shares of Merck & Co., Inc. (NYSE:MRK) on strength during trading hours on Tuesday. $82.37 million flowed into the stock on the tick-up and ...

Burundi Head of State receives Merck Foundation President.  RegionWeek

Burundi Head of State has received the President of Merck BUJUMBURA Foundation on March 19, 2019, in Bujumbura, the economic capital of Burundi.

Merck Takes Versum Bid Hostile With Proxy Vote Proposal  Bloomberg

Merck KGaA went hostile with its $5.9 billion bid for Versum Materials Inc., appealing directly to shareholders for votes against the semiconductor-components ...

How Much Can Merck's Share Price Grow If Keytruda Gets 10% Share Of Oncology Drug Market?  Forbes

Merck's (NYSE:MRK) Keytruda has been on a strong run with sales exceeding $7 billion in 2018. This can be attributed to its superior benefits in lung cancer, ...

Analysts: Keytruda has a blockbuster market not factored into Merck's forecasts?China  FiercePharma

Merck & Co.'s Keytruda is already the best-selling immuno-oncology drug on the market, but as one group of analysts sees it, the drug still has one key upside ...

Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer  PRNewswire

DARMSTADT, Germany and NEW YORK, March 19, 2019 /PRNewswire/ -- Not intended for UK-based media Merck KGaA, Darmstadt, Germany, which operates ...

Germany's Merck makes $5.9 billion counterbid for Versum  Reuters

FRANKFURT (Reuters) - German drugs and lab supplies maker Merck KGaA offered $5.9 billion, including debt, for Versum Materials, in a cash deal that tops ...

Versum, Entegris see extra merger benefits, Merck hires Goldman  Reuters

Entegris and Versum Materials on Friday highlighted additional benefits from their planned all-share merger, while rival bidder Merck KGaA said it had brought ...

Key drugs from Merck, Roche win wider EU approvals  BioPharma Dive

The European Commission on Thursday approved label expansions that broaden the market for key therapies from pharma companies Roche and Merck, ...

Reuters: UPS eyes health logistics market with home vaccine test  Seeking Alpha

Facing competitive pressures from, [[UPS]] is readying a test of a home vaccination *service* that would provide further inroads into healthcare l.

Merck KGaA encouraged by market reaction to Versum swoop  Reuters

DARMSTADT, Germany (Reuters) - German drugs and lab supplies group Merck KGaA is encouraged by the market reaction to its unsolicited bid for Versum, ...

As Merck boosts R&D pact, NGM Bio gains Genentech, Lilly veteran as new R&D chief  FierceBiotech

It's a pretty good news day for NGM Bio: Merck doubled down on its R&D pact and it's nabbed a Genentech executive to help run its trials.

Merck and Iktos to form AI alliance  PharmaTimes

Merck has announced an AI-based collaboration with Iktos. - News - PharmaTimes.

Merck, King's Launch $344M+ Chronic Pain Drug Collaboration  Genetic Engineering & Biotechnology News

Merck & Co. plans to develop a new class of pain treatments using technology developed by Prof Peter McNaughton, FMedSci, of King's College London, ...

Drexel's 2019 commencement speaker announced: Merck CEO Kenneth Frazier  Drexel University The Triangle Online

Merck & Co., Inc. Chairman and CEO Kenneth C. Frazier will be speaking at Drexel's 2019 commencement ceremony at Citizens Bank Park June 14. Frazier is ...

Merck limits orders for bladder cancer drug as demand outstrips supply  FiercePharma

Merck has served as the sole supplier of an important drug for years, and now the company says it can't keep up. It's implementing order limits for countries ...

UPDATE 1-Versum Materials rejects Merck KGaA's unsolicited offer  Reuters

(Adds Merck comment, background). March 1 (Reuters) - Electronic materials maker Versum Materials Inc on Friday formally rejected a $5.9 billion unsolicited ...

Merck (MRK) Gains But Lags Market: What You Should Know

Merck (MRK) closed the most recent trading day at $81.60, moving +0.46% from the previous trading session.

Merck gives King's College London, Wellcome Trust up to $340M in deal to develop non-opioid painkillers  Endpoints News

The hyperpolarization-activated cyclic nucleotide-gated (HCN) channel comprises four members (HCN1-4) that are expressed in the heart and nervous system ...

Merck's Stock Signals Bearish Warning Signs  Seeking Alpha

Bearish options betting has taken place in the stock in recent days. The technical chart suggests the shares may reverse. The valuation for the stock is reachin.

Why Merck (MRK) is a Great Dividend Stock Right Now  Yahoo Finance

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find ...

Anatomy of a deal: How Merck closed Immune Design for $300M  FierceBiotech

Two weeks ago, Merck & Co. announced its plan to buy out Immune Design?a biotech working on immunotherapies for non-Hodgkin lymphoma, respiratory ...

2019-03-22  Outlook India

Merck Ltd. opened at Rs. 3400.00 today after closing at Rs. 3376.05 yesterday. The opening price of today was observed to have increased 97.4 points as ...

Merck & Co 5-Year Buy-And-Hold Turned $10K Into This  MMJ Stock Watch

?I buy on the assumption that they could close the market the next day and not reopen it for five years.? ? Warren Buffett. POPULAR: Top Dividend Paying Stocks ...

After a slate of small, tack-on acquisitions, is Merck ready to pull the trigger on a big M&A deal?  Endpoints News

Like any good big pharma CEO, Merck's Ken Frazier likes to paint a big, positive picture when he talks with analysts about R&D. But in his latest quarterly ...

ACC: Merck anacetrapib reveal bodes neutral at best for DalCor's dalcetrapib  FierceBiotech

At the annual meeting of the American College of Cardiology this week, a new analysis of data for Merck's anacetrapib cast a shadow on DalCor's ...

Enigma Biomedical Group Signs License Agreement with Merck for Novel MK-6884 Imaging Agent  Hastings Tribune

TORONTO--(BUSINESS WIRE)--Mar 15, 2019--Enigma Biomedical Group (EBG) today announced an exclusive license agreement with Merck, known as MSD ...

Merck restricts bladder cancer drug shipments amid shortage  Becker's Hospital Review

Merck, the sole supplier of a critical bladder cancer drug, is restricting shipments of the treatment as demand outpaces supply.

These Stocks Could Change Your Future ? Merck & Co., Inc. (MRK), E*TRADE Financial Corporation (ETFC)  CryptoAmber

There were 11.35 million Merck & Co., Inc. (NYSE:MRK) shares traded at the market, while its stock closing price for March 20th, 2019 was placed at $81.91, ...

No Concerns In Sight For Etsy, Inc. (ETSY), Merck & Co., Inc. (MRK)  The RNS Daily

Over the past 52 weeks, the shares of Etsy, Inc. (NASDAQ:ETSY) has been trading as low as $26.54 before witnessing a massive surge by 159.61% or $42.36.

Merck KGaA profit rises on sales growth  MarketWatch

German multinational Merck KGaA (MRK.XE) said Thursday that its fourth-quarter net profit more than doubled as sales rose in its three business sectors.

Brainstorm Health: Stem Cells in Space, CVS Stock Plunge, Merck Setback  Fortune

Hello and happy hump day, readers. Biopharma can come across as having otherworldly ambitions. So why not take matters, literally, to outer space?

Top Research Reports for Merck, Adobe & Broadcom

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, ...

Merck Reviews US Corporate PR Support  The Holmes Report

Agencies that already do work for the pharmaceutical giant are among those participating in the review.

Scholar thinks Glaxo made a wise move to back Merck  Vantage

Scholar Rock selects a lead molecule inhibiting TGF-?, an increasingly important oncology mechanism that Glaxosmithkline recently paid ?300m to enter.

Analysis: CEOs From Pfizer, Merck, AbbVie and Others Face Senate on Drug Prices  The Wall Street Journal

Rising drug prices were in focus as pharmaceutical industry executives testified before the Senate Finance Committee, with lawmakers taking issue with how ...

Merck Shares Drop After Keytruda Treatment Fails Late-Stage Liver Cancer Trial

Merck shares slipped lower in pre-market trading Wednesday after the drugmaker said one of its key liver cancer treatments failed a late-stage trial only months ...

Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China content=  PR Newswire UK

Collaboration to build global-standard platform for plasmid and virus manufacturing in China - Merck plans to provide comprehensive products, services and...

Merck Gets Priority Review for Keytruda in Third-Line SCLC

Merck's (MRK) sBLA looking for approval of Keytruda monotherapy for the third-line treatment of small cell lung cancer, a difficult-to-treat cancer, gets FDA's ...

The Zacks Analyst Blog Highlights: Merck, Adobe, Broadcom, AstraZeneca and Ross Stores  Nasdaq

For Immediate Release Chicago, IL -March 19, 2019 - announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity.

Germany?s Merck posts 10% earnings slide after forex losses  Financial Times

Germany's Merck has reported a double-digit decline in underlying earnings last year after taking a hit from foreign exchange losses.

Merck Chairman and CEO Kenneth Frazier to Speak at Drexel's 2019 Commencement - DrexelNow  Drexel Now

Merck & Co., Inc. Chairman and CEO Kenneth C. Frazier will address the class of 2019 at Drexel's University-wide commencement ceremony on June 14.

Merck notches fourth lung cancer approval in Europe for flagship Keytruda  Endpoints News

Merck's keystone immunotherapy Keytruda has won yet another lung cancer approval in Europe, this time as the first line of defense for patients with metastatic ...

Judge Rejects Plaintiff Firms' Demand for More Fees in Merck Securities MDL | New Jersey Law Journal

A federal judge in Newark has dismissed a lawsuit from two law firms claiming they were shortchanged on fees after referring a plaintiff to the Vioxx securities ...

Merck does not have to compensate French patients, court rules  DW (English)

A court in France has thrown out a lawsuit against German pharmaceutical company Merck. More than 4000 patients took the drug manufacturer to court after it ...

Why Merck (MRK) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find ...

Merck awards scholarships to more than 50 veterinary students  National Hog Farmer

Merck Animal Health, in partnership with the American Veterinary Medical Foundation, awards 54 veterinary students from around the world scholarships ...

Merck to contribute $200 million to global pension plans  Pensions & Investments

Merck & Co. Inc., Kenilworth, N.J., plans to contribute about $200 million to its global defined benefit plans in 2019, the company disclosed in its 10-K filing on ...

Analysts Downgrade Merck and Pfizer on Patent Cliff, Exclusivity Concerns

Last month, business news outlets were reporting that stock prices for pharmaceutical firms Pfizer and Merck took a tumble after financial analysts downgraded ...

Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda

Merck (MRK) gets CHMP recommendation for a six-week dosing schedule of Keytruda across all current monotherapy indications.

Thursday?s Vital Data: Aurora Cannabis, Roku and Merck

Options trading was buzzing in Aurora Cannabis, Roku and Merck on Wednesday. Here are the metrics that matter moving forward.

FedEx Corporation (NYSE:FDX), Merck & Company, Inc. (NYSE:MRK) - FedEx's Struggles May Be Less About Global Demand And More About 'NotPetya'  Benzinga

FedEx's struggles could have roots in the 'NotPetya' cyberattack. (Photo: Facebook/FedEx) FedEx Corp. (NYSE: FDX) and arch-rivals UPS Inc. ...

King's College scientist inks potential $340M Merck deal for chronic pain program  BioWorld Online

BioWorld Online is the news *service* of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date ...

Temozolomide Market Share and Growth 2019: Merck, SL Pharme, Sun Pharma, Mayne Pharma - Press Release  Digital Journal

This press release was orginally distributed by SBWire. Los Angeles, CA -- (SBWIRE) -- 03/21/2019 -- The global Temozolomide market is valued at million US$ ...

The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J  Nasdaq

For Immediate ReleaseChicago, IL -March 18, 2019 - announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity.

Merck KGaA, Pfizer Join BioXcel-Nektar Collaboration, Creating Triple Combination Therapy for Pancreatic Cancer  Genetic Engineering & Biotechnology News

Pfizer and Merck KGaA, Darmstadt, Germany, have joined BioXcel Therapeutics in its clinical collaboration with Nektar Therapeutics, creating an expanded ...

What Makes Merck & Company (NYSE:MRK) and Boston Scientific Corp (NYSE:BSX) A Compelling Stock?Apps for PC Daily  AppsforPCdaily

Merck & Company (NYSE:MRK) shares traded up 0.21% during most recent session. Wall Street analysts covering the stock are projecting that the stock will ...

Merck expands Mass. reach with Torque cancer collaboration  Boston Business Journal

Cambridge biotech Torque has become the latest local startup to team up with New Jersey drug giant Merck & Co., announcing a collaboration this week to ...

Eager to think bigger than China, Ascletis woos top Merck exec to run R&D  Endpoints News

Having paved the way in developing and commercializing China's first home-cultivated hepatitis C drug ? with some help from a multinational pharma partner ...

French court dismisses damages claims against Merck over thyroid drug  Reuters

A court in the French city of Lyon threw out on Tuesday claims made by 4113 plaintiffs for damages against Merck over changes to its thyroid drug Levothyrox.

Merck KGaA urges Versum shareholders to pipe up for rival bid  Yahoo Finance

Germany's Merck KGaA called on Versum Materials Inc's shareholders to put pressure on the electronic materials maker's management to consider its jilted ...

Merck's Roger Perlmutter pays $300M to scoop up a battered Immune Design for its I/O work  Endpoints News

Just months after Immune Design triggered an exodus of investors with news of a Phase II setback on its leading immuno-oncology work, Merck has stepped up ...

Will GSK/Tesaro's Checkpoint Inhibitor Be Able to Compete With Merck's Keytruda?  BioSpace

Only a few months after GlaxoSmithKline acquired Waltham, Mass.-based Tesaro, Tesaro released promising data from its Phase I/II GARNET study of ...

Are Analysts Seeing Upside To Merck & Co., Inc. (MRK), Analog Devices, Inc. (ADI)?  The RNS Daily

Merck & Co., Inc. (NYSE:MRK) average daily volatility for this week is 1.1% which is less than the 1.27% recorded over the past month. Its shares dropped by ...

Merck KGaA CEO Sees Healthy Growth in 2019  Bloomberg

Stefan Oschmann, chief executive officer at Merck KGaA, discusses his 2019 earnings forecast, the U.S. approval of their multiple sclerosis drug, the progress of ...

Quant Value Comp Score Pushes to 51 For Merck & Co., Inc. (MRK)  Stock News Oracle

Taking a look at valuation rankings for Merck & Co., Inc. (MRK), we see that the stock has a Value Composite score of 51. Developed by James.

Dow Jones Futures: Merck Stock, Five9 Stock, Cadence Design Stock, OneSpan Stock Are Notable Movers  Investor's Business Daily

Dow Jones futures were little changed early Wednesday, along with S&P 500 futures and Nasdaq futures, after the current stock market rally cleared another ...

Ramping up the expectation: Ford Motor Company (F), Merck & Co., Inc. (MRK)  FinBulletin

Since the start of this financial year stock price of the Ford Motor Company (NYSE: F)has maneuvered across quite a bit, with a year-to-date change of +1.05.

Merck KGaA Crashes Into The Versum-Entegris Tie-Up  Seeking Alpha

Merck KGaA, Darmstadt, Germany, inserts itself into the conversation with an unsolicited all-cash bid for Versium that represents a double-digit premium to Ente.

Merck (MRK), AstraZeneca (AZN) Say LYNPARZA Reduced Risk of Disease Progression or Death as First-Line Maintenance Treatment in gBRCAm

AstraZeneca (NYSE: AZN) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 ...

Swine Diagnostic Testing Market 2018-19 Merck Sharp & Dohme, Qiagen, Elanco  The Market Research News

Swine Diagnostic Testing Market presents overview: A recent market report published on the ?Swine Diagnostic Testing Market? presents an in-depth overview ...

Merck Foundation calls for Applications for ?Merck More Than a Mother? Fashion Awards in partnership with the First Lady of Zambia and Zambia Fashion Week  africanews

Merck Foundation (, the philanthropic arm of Merck KGaA Germany announces the Call for Application of ?Merck More Than a ...

Merck begins tender offer for Immune Design  Seeking Alpha

Merck (MRK) has begun its tender offer for all the outstanding shares of Immune Design (IMDZ) at $5.85 per share. The company first announced the deal on F.

Merck & Co pens $340m pain drug deal with KCL and Wellcome  pharmaphorum

Merck & Co has announced a deal with King's College London and the Wellcome Trust to investigate a new class of painkillers.

Merck KGaA 2018 Q4 - Results - Earnings Call Slides  Seeking Alpha

The following slide deck was published by Merck KGaA in conjunction with their 2018 Q4 earnings call.

Three stocks including P&G just hit highs. Here's why there could be more upside  CNBC

The S&P 500 may still be 5 percent from its record high, but a handful of stocks have soared to highs, including Merck, Mastercard, P&G, Cisco and Estee ...

Streetwise Analysis on Shares of Merck & Co., Inc. (NYSE:MRK)  Hartsburg News

Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low ...

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More  Xconomy

Xconomy National ?. The growing epidemic of the fatty liver disease known as NASH, which has no FDA-approved treatment, has led to a frenzied race among ...

Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering  Benzinga

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) ...

Merck & Co., Inc. (NYSE: MRK), Aurora Cannabis Inc. (NYSE: ACB) - Is It Really A Good Time To Be Buying Options?  News Parents

A price target is the projected price level of a financial security stated by an investment analyst or advisor and includes assumptions of future activity. It speaks to ...

Skin Moisturizers Market Overview and Scope with key players Merck KGaA, BASF, Res Pharma, Dow Corning Corporation, Croda, Innospec Performance Chemicals  Operanewsnow

A new business intelligence report released by HTF MI with title ?EMEA (Europe, Middle East and Africa) Skin Moisturizers Market Report 2018? has abilities to ...

For more news about Merck & Company click here:
Merck & Company News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2019 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources